Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Mar;84(3):300–302. doi: 10.1136/bjo.84.3.300

Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids

Y Alster 1, L Herlin 1, M Lazar 1, A Loewenstein 1
PMCID: PMC1723401  PMID: 10684842

Abstract

AIMS—To investigate the intraocular penetration of vancomycin eye drops and to compare the conventional method of drop instillation to the lower cul de sac with applying drops to the medial canthus with closed lids.
METHODS—This prospective randomised trial evaluated 53 eyes of 53 patients who had undergone extracapsular cataract extraction (ECCE) with intraocular lens implantation. Vancomycin (50 mg/ml) eye drops were applied to either the lower cul de sac with open lids (conventional method), or to the medial canthus with the patient in a supine position and with closed lids. After paracentesis performed during ECCE, an aqueous humour sample was taken and vancomycin concentration was measured using the TDX vancomycin assay (fluorescence polarisation immunoassay).
RESULTS—Vancomycin concentration in the anterior chamber were above the minimal inhibitory concentration for Gram positive bacteria in the two methods of drop instillation examined (2.04 (SD 1.9) µg/ml and 1.49 (1.1) µg/ml in the open and closed methods, respectively (p =0.202)).
CONCLUSIONS—Vancomycin (50 mg/ml) reaches therapeutic concentration in the anterior chamber after topical drop application. Comparable concentrations were reached when drops were applied in either the lower cul de sac or to the medial canthus with closed lids. The latter method is proposed as likely to improve patient compliance.



Full Text

The Full Text of this article is available as a PDF (84.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Choi T. B., Lee D. A. Transscleral and transcorneal iontophoresis of vancomycin in rabbit eyes. J Ocul Pharmacol. 1988 Summer;4(2):153–164. doi: 10.1089/jop.1988.4.153. [DOI] [PubMed] [Google Scholar]
  2. Halberg G. P., Kelly S. E., Morrone M. Drug delivery systems for topical ophthalmic medication. Ann Ophthalmol. 1975 Sep;7(9):1199-1204, 1207-9. [PubMed] [Google Scholar]
  3. Huerva V., Sinués B., del Buey M. A., Cristóbal J. A., Mínguez E., Lanuza J., Palomar A. Levels of vancomycin in aqueous humor after topical eye drops administration. J Ocul Pharmacol. 1993 Summer;9(2):167–170. doi: 10.1089/jop.1993.9.167. [DOI] [PubMed] [Google Scholar]
  4. Lebensohn J. E. Letter: The eyedrop. Am J Ophthalmol. 1974 Apr;77(4):600–602. doi: 10.1016/0002-9394(74)90483-8. [DOI] [PubMed] [Google Scholar]
  5. Letocha C. E. Methods for self-administration of eyedrops. Ann Ophthalmol. 1985 Dec;17(12):768–769. [PubMed] [Google Scholar]
  6. Loewenstein A., Bolocinic S., Goldstein M., Lazar M. Application of eye drops to the medial canthus. Graefes Arch Clin Exp Ophthalmol. 1994 Nov;232(11):680–682. doi: 10.1007/BF00171384. [DOI] [PubMed] [Google Scholar]
  7. Mishima S. Clinical pharmacokinetics of the eye. Proctor lecture. Invest Ophthalmol Vis Sci. 1981 Oct;21(4):504–541. [PubMed] [Google Scholar]
  8. PRYOR J. G., APT L., LEOPOLD I. H. Intraocular penetration of vancomycin. Arch Ophthalmol. 1962 May;67:608–611. doi: 10.1001/archopht.1962.00960020608015. [DOI] [PubMed] [Google Scholar]
  9. Phinney R. B., Schwartz S. D., Lee D. A., Mondino B. J. Collagen-shield delivery of gentamicin and vancomycin. Arch Ophthalmol. 1988 Nov;106(11):1599–1604. doi: 10.1001/archopht.1988.01060140767052. [DOI] [PubMed] [Google Scholar]
  10. Sasaki H., Yamamura K., Mukai T., Nishida K., Nakamura J., Nakashima M., Ichikawa M. Enhancement of ocular drug penetration. Crit Rev Ther Drug Carrier Syst. 1999;16(1):85–146. [PubMed] [Google Scholar]
  11. Stolovitch C., Alster Y., Goldstein M., Loewenstein A., Lazar M. Application of cyclopentolate 1% to the medial canthus in children. J Pediatr Ophthalmol Strabismus. 1998 May-Jun;35(3):182–184. doi: 10.3928/0191-3913-19980501-16. [DOI] [PubMed] [Google Scholar]
  12. Winfield A. J., Jessiman D., Williams A., Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 1990 Aug;74(8):477–480. doi: 10.1136/bjo.74.8.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zimmerman T. J., Ziegler L. P. Successful topical medication: methodology as well as diligence. Ann Ophthalmol. 1984 Feb;16(2):109–109. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES